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Background: As many as 30% of patients who start pulmonary rehabilitation (PR) fail to com-
plete it, and depressed mood has been associated with PR non-completion. Depression is more
common in women than men with COPD and historically women with COPD have been under
studied. However, no studies to date have investigated gender-specific predictors of PR
completion.
Methods: The study included 111 patients with COPD who enrolled in a community based
outpatient PR program in Providence, RI. Patients who attended 20 or more sessions were
designated “completers”. Depression was measured using the CES-D. Logistic regression
models were evaluated to test depressed mood as a predictor of PR completion. Analyses
controlled for demographic and health variables found to differ between completers and
non-completers.
Results: Patients were 95% white and 49.5% women, and 74% had a GOLD stage 3. Sixty-eight
percent of patients were PR completers. A logistic regression model, showed that lower
depressed mood independently predicted PR completion across all patients (adjusted
OR Z 0.92, p Z .002). In gender-stratified analyses, lower depressed mood was an indepen-
dent predictor of PR completion for women (adjusted OR Z .91, p Z .024) but not men
(adjusted OR Z .97, p Z .45). Greater 6-min walk test distance was also an independentHospital, Centers for Behavioral & Preventive Medicine, Coro West, Suite 309, 164 Summit Ave,
01 793 8189; fax: þ1 401 793 8059.
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Conclusion: Depressed mood is an important predictor of completion of community based PR
among women. Screening and brief treatment of depression should be considered in practice.
ª 2014 Elsevier Ltd. All rights reserved.Chronic obstructive pulmonary disease (COPD) is a common
and often disabling inflammatory lung disease character-
ized by progressive airway obstruction that is not fully
reversible [1,2]. An important component of non-
pharmacologic treatment for COPD is multidisciplinary
pulmonary rehabilitation (PR), which improves exercise
tolerance, perceived dyspnea, depression and anxiety, and
health-related quality of life [2e5]. The minimum recom-
mended duration for PR is six weeks [2], with longer pro-
grams being more effective [6,7]. However, as many as 30%
of patients who begin PR programs drop out prematurely
[8e11].
Several studies have identified baseline variables that
predict PR non-completion [11], including depressed mood.
Depressive symptoms and Major Depressive Disorder are
common among patients with COPD [12,13], and have been
associated with increased mortality, greater symptom
burden and increased hospitalization, decreased func-
tioning, and diminished quality of life [13e19]. High rates
of depression among those with COPD appear to be at least
partially caused by the activity limitations due to COPD
[20], which is similar to findings in other chronic illnesses
[21].It is well-established that women in the general pop-
ulation experience higher rates of depression relative to
men, and this gender difference has also been observed
among those with COPD [13,22,23]. Women may also be
more likely to become depressed after a COPD diagnosis
and greater duration of COPD increases the risk of devel-
oping depression in women but not men [13].
Women have historically been woefully underrepre-
sented in COPD research [24]. To our knowledge, no studies
have evaluated predictors of PR completion separately for
male and female PR attendees. Further, the only data on
predictors of PR completion from US based samples have
included a disproportionate percentage of men (61e96%)
[25,26]. Therefore, the current study was designed to
investigate gender specific predictors of completion of a
comprehensive US community-based PR program, with a
focus on investigating depressed mood. We hypothesized
that depressed mood will be an independent predictor of
PR completion in both genders after controlling for relevant
covariates.
Method
This sample was drawn from patients attending a compre-
hensive outpatient PR program in Providence, RI. The PR
treatment team includes an exercise physiologist, respira-
tory therapist, physical therapist, clinical psychologist, and
MD pulmonologist. The PR program includes assessment,
treatment, and education for patients with COPD and other
respiratory disorders. The clinical psychologist (MLB) con-
ducted an in person evaluation with PR patients at intake. Ifpatients reported significant illness adjustment issues,
stress, depressed mood, or anxiety, they were offered brief
psychotherapy. In general psychotherapy focused on pul-
monary specific adjustment issues, such as a) accepting
functional limitations, b) adherence to medications and
oxygen use, c) pacing of activities and prioritizing most
important activities, and d) not judging self-worth based on
the quantity of tasks performed. Cognitive behavioral in-
terventions were provided as needed to treat depression
and anxiety symptoms.
Patients are expected to attend this PR program twice a
week for 20e36 total sessions. Because the number of PR
sessions pre-approved by local insurance providers ranged
from 20 to 36 sessions and because at the time of data
collection Medicare capped PR attendance at 36 lifetime
sessions, it was program policy to consider planned
discharge after 20 sessions (in the case of Medicare
coverage, so that patients could save some lifetime sessions
for future exacerbations). These planned discharge de-
cisions also incorporated patient progress (especially
progress towards patient functional goals) and ability to
exercise independently following discharge. All patients in
our sample described below were pre-approved by their
public or private insurance company at PR intake for at
least 20 sessions. Therefore, for the current study, patients
who attended 20 or more sessions were designated as
completers and those who attended fewer than 20 sessions
as non-completers.
Participants
Data were obtained by combining an existing quality
improvement database (which included all standardized
intake measures listed below) and a retrospective chart
review (to confirm diagnostic/co-morbidity status and
collect demographic and attendance data) of patients
enrolled in the PR program. All patients meeting formal
COPD criteria (i.e., FEV1/FVC < ) and enrolled in the pro-
gram between October 2007 and February 2012 were
reviewed for inclusion.
We first identified patients that would likely have a
diagnosis of COPD (i.e., those with a ICD-9 diagnostic code
indicating a chronic airway obstruction) and who had valid
scores on all of our primary standardized measures (i.e.,
complete data at intake on the CES-D, all 4 subscales of the
Chronic Respiratory Questionnaire (CRQ) [27] the 6-min
walk test, and an FEV-1 test) in the existing quality
improvement database. This produced 146 patients whose
charts were selected for review. Of these 146 patients,
medical charts from 17 were unavailable for review. A total
of 129 charts were reviewed. Of these 129 patients, med-
ical charts indicated that 18 patients had a FEV1/FVC ratio
>0.7, indicating they did not meet formal criteria for COPD
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with COPD who started at PR.Measures
All demographics, smoking history and oxygen use were
obtained through patient self-report at intake. Travel dis-
tance was calculated by determining the distance from the
patient’s home address to the PR clinic using a web based
mapping tool. BMI was calculated using the height and
weight measured by staff.
The Global Initiative for Chronic Obstructive Lung Dis-
ease (GOLD) criteria was used for the diagnosis and severity
of COPD for the current study. Spirometry valuesdforced
expiratory volume 1s (FEV1) and forced vital capacity (FVC)
post-bronchodilatorsdwere obtained and evaluated
against the cutoff for diagnosis (FEV1/FVC < 0.70). Severity
is classified into four “GOLD stages”. Gold I is mild
(FEV1  80% predicted), Gold II is moderate
(50%  FEV1 < 80% predicted), Gold III is severe
(30%  FEV1 < 50% predicted) and Gold IV is very severe
(FEV1 < 30% predicted).
Patients completed the Chronic Respiratory Question-
naire (CRQ) [27] to assess disease-related quality of life.
The CRQ comprises four core domains, three of which use
standardized items rated on a Likert scaledfatigue (4-
items), emotional functioning (7-items), and mastery (4-
items). The fourth domainddyspnea (5-items)dis based
on self-report of shortness of breath while performing
personally relevant activities. Higher scores on CRQ do-
mains indicate better functioning, and a 0.5 change in
domain score is considered clinically significant [28].
Exercise tolerance was measured by the 6-min walk test
(SMWT) [29] in general accordance with the guidelines of
American Thoracic Society. We modified the SMWT by
having test administrators walk with patients as they
completed the test and, with patients enrolled before
2010, they carried oxygen tanks for the patient. Number of
feet walked (NFW) was used for the current analysis.
The Center for Epidemiologic Studies Depression Scale
(CES-D) [30] was used to measure depressed mood. This 20-
item measure assesses depressive symptoms over the past
week. Scores range from 0 to 60, with scores 16 suggestive
of a major depressive disorder [30].1 We did not control for CRQ-emotional functioning in the overall
model because there is significant content and conceptual overlap
between this sub-scale and depression symptoms measured by the
CESD (r Z 0.67, p < .001).Analytic plan
Summary statistics (frequencies, means and standard de-
viations) were used to describe the sample characteristics,
health indicators, pulmonary function, and psychosocial
variables by PR completion and gender. Differences be-
tween completers and non-completers were examined
using a series of bivariate analyses (chi-square, Fisher’s
exact test, or one-way analysis of variance), stratified by
gender. Demographic and health variables that were
significantly different between men and women completers
and non-completers were included in subsequent analyses.
Logistic regression models, conducted separately for the
overall sample and by men and women, were evaluated to
test our hypothesis that depressed mood predicts PRprogram completion. All data analyses were conducted
using Stata 12 [31].Results
Characteristics of the overall sample
Patients (N Z 111; 95% White) were men (n Z 56) and
women (n Z 55) between 34 and 89 years of age
(median Z 70) enrolled in an outpatient PR program. Less
than half of the patients reported any post-secondary ed-
ucation (44%); few were currently employed (15%). Many
patients were married (53%; 30% widowed, 13% divorced,
5% never married) and/or cohabitating (54% with a partner
and 18% with another individual). Patients lived an average
of 11 miles (SDZ 13) from the outpatient PR program site.
Most patients were former smokers (95%); few patients
reported never smoking (5%). Former smokers smoked an
average of 41 years (SDZ 12) and had quit for a median of
7 years (ranging from less than 1 year to 55 years). Less than
half of the patients (48%) required home oxygen use. Most
patients were overweight or obese (66%) with an average
body mass index (BMI) of 29 (range Z 16e55). Patients
reported a number of medical co-morbidities including or-
thopedic (41%), heart disease (25%), diabetes (17%), asthma
(12%), cancer (7% lung; 9% other cancers), and neurological
conditions (8%). Half of the patients (51%) were classified as
having severe COPD (GOLD Stage III); 23% with very severe
COPD (GOLD Stage IV) and 23% with moderate COPD (GOLD
Stage II). Patients walked a median of 816 feet in the SMWT
(range Z 135e1567).Pulmonary rehabilitation program completion
Of the 111 patients included in the study, 68% (n Z 75; 39
men and 36 women) completed at least 20 sessions (i.e.,
completers). Patients who did not complete 20 sessions
(32%; i.e., non-completers), attended, on average, 11 ses-
sions (range Z 1e19). There were no differences between
completers and non-completers on any demographic vari-
able at intake (data not shown). Completers differed from
non-completers with respect to co-morbidities and psy-
chosocial functioning at intake. Compared with non-
completers, completers were less likely to be diabetic (X2
[1] Z 4.27, p Z .039), were higher in CRQ-emotional
functioning (F [1, 109] Z 6.25, p Z .014), and reported
fewer depressive symptoms (F [1, 109] Z 12.36, p < .001).
A logistic regression model, controlling for diabetes,1
showed that depressed mood was a significant predictor
of PR program completion, adjusted OR Z 0.92 (95%
CI Z 0.88, 0.97), p Z .002. Diabetes status continued to
predict a lower likelihood of completion in the multivariate
model adjusted OR Z .31 (95% CI Z 0.11, 0.90), p Z .03.
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stratified by men and women
Data for the patients stratified by PR completion and
gender are reported in Table 1. There were no within
gender differences between completers and non-
completers on any demographic variable (see Table 1).Table 1 Characteristics of men and women by pulmonary reha
Men
Completers
(n Z 39)
Demographics
Age, M years (SD) 70 (10)
Caucasian, n (%) 37 (95)
Married, n (%) 26 (70)
Cohabitation, n (%) 32 (82)
College education, n (%) 17 (46)
Employed, n (%) 7 (18)
Travel distance, M miles (SD) 12 (7)
Health indicators
Smoking status
Never smoker, n (%) 1 (3)
Former Smoker, n (%) 38 (97)
Smoking duration, M years (SD) 40 (14)
Smoking cessation, M years (SD) 13 (14)
Home oxygen use, n (%) 18 (47)
Body mass index, M (SD) 27 (6)
Co-morbid pulmonary conditions, n (%)
Asthma 3 (8)
Sleep apnea 1 (3)
Pulmonary hypertension 1 (3)
Lung cancer 4 (10)
Other pulmonary 2 (5)
Other co-morbid conditions, n (%)
Diabetesb 7 (18)
Heart disease 13 (33)
Neurological 2 (5)
Orthopedic 14 (36)
Cancer (not including lung) 5 (13)
Other major 1 (3)
Total no. of co-morbid conditions, M (SD) 1 (<1)
Pulmonary function
GOLD stage, n (%)
I 1 (3)
II 6 (15)
III 21 (54)
IV 11 (28)
FEV1, M (SD) 0.40 (0.17)
6-min walk distance M (SD)b 850 (322)
Chronic respiratory questionnaire M (SD)c
Dyspnea 3.30 (1.17)
Fatiguea 4.06 (1.03)
Emotional Functioning 5.02 (1.13)
Mastery 4.82 (1.33)
Depression (CES-D) M (SD)a,b 11.67 (7.33)
a Indicates significant completer vs. non-completer differences amo
b Indicates significant completer vs. non-completer differences amo
c Higher scores on Chronic Respiratory Questionnaire domains indicThere were no differences between completers and non-
completers on health indicators; completers and non-
completers differed on co-morbidities, pulmonary func-
tion, and depressed mood (see Table 1). Among women,
completers were less likely to be diabetic (p Z .041, two-
tailed Fisher’s exact test), performed better on the 6-min
walk distance (F [1, 54] Z 5.13, p Z .028), and hadbilitation program completion.
Women
Non-completers
(n Z 17)
Completers
(n Z 36)
Non-completers
(n Z 19)
70 (14) 70 (9) 67 (13)
16 (94) 36 (100) 17 (89)
13 (81) 12 (34) 4 (25)
14 (82) 22 (61) 11 (61)
8 (53) 14 (42) 6 (35)
3 (18) 5 (14) 2 (11)
9 (4) 8 (5) 8 (5)
0 (0) 3 (8) 1 (5)
17 (100) 33 (92) 18 (95)
42 (10) 40 (10) 42 (12)
11 (14) 10 (9) 7 (7)
7 (41) 18 (50) 10 (53)
30 (5) 29 (8) 29 (9)
4 (24) 4 (11) 2 (11)
1 (6) 1 (3) 0 (0)
1 (6) 0 (0) 0 (0)
0 (0) 3 (8) 1 (5)
0 (0) 2 (6) 1 (5)
5 (29) 2 (6) 5 (26)
9 (53) 2 (6) 4 (21)
2 (12) 4 (11) 1 (5)
9 (53) 16 (44) 6 (32)
1 (6) 3 (8) 1 (5)
0 (0) 2 (6) 1 (5)
2 (<1) <1(<1) <1(1)
0 (0) 1 (3) 0 (0)
3 (18) 11 (31) 6 (32)
12 (71) 15 (42) 9 (47)
2 (12) 9 (25) 4 (21)
0.41 (0.12) 0.44 (0.15) 0.41 (0.14)
875 (414) 851 (384) 629 (256)
2.93 (1.24) 2.97 (1.09) 2.72 (1.11)
3.25 (1.18) 3.64 (1.24) 3.61 (1.21)
4.34 (1.52) 4.87 (1.20) 4.32 (1.20)
4.37 (1.56) 4.68 (1.35) 4.20 (1.31)
17.47 (11.67) 11.17 (7.20) 17.84 (11.34)
ng men (p  .05).
ng women (p  .05).
ate better functioning.
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completers. For men, only the CRQ-fatigue and depressed
mood differed with completers reporting significantly less
fatigue (F [1, 55] Z 6.70, p Z .012) and fewer depressive
symptoms (F [1, 55] Z 5.10, p Z .028) than non-
completers.
Two separate logistic regression models, stratified by
gender, were conducted to evaluate whether depressed
mood was a significant independent predictor of PR pro-
gram completion. The first model, controlling for diabetes
and 6-minute walk distance, showed that depressed mood
was a significant independent predictor of PR program
completion for women, adjusted ORZ 0.91 (95% CIZ 0.84,
0.99), p Z .024 (see Fig. 1). Six-minute walk distance
remained a significant predictor in this model (adjusted
ORZ 1.00, 95% CIZ 1.0003, 1.0037, pZ .02), but diabetes
status did not (adjusted OR Z 0.18, 95% CI Z 0.03, 1.25,
p Z .08).
A second model, controlling for CRQ-fatigue, showed
that depressed mood was not significantly related to PR
program completion for men, adjusted OR Z 0.97 (95%
CIZ 0.89, 1.05), pZ .45 (see Fig. 1). CRQ-Fatigue was also
non-significant in this model (adjusted OR Z 1.66, 95%
CI Z 0.86, 3.20, p Z .13).
To explore the differential effect of CRQ-fatigue in men
and women, in a post hoc analysis we compared the cor-
relation between depressed mood and CRQ-fatigue be-
tween men and women. Depressed mood was significantly
more correlated with CRQ-fatigue in men (r Z .62) than
in women (r Z .32; Z Z 2.02, p Z .04).
Discussion
A significant minority of patients (32%) were non-
completers, which is consistent with previously reported
rates of PR non-completion. When all patients were
included in the analyses, depressed mood was found to be a
strong predictor of PR completion in both bivariate and
multivariate analyses, which is consistent with prior
research [11]. However, differences emerged when men
and women were analyzed separately; in multivariate an-
alyses depressed mood was a significant predictor ofFigure 1 Predicted probability of completing the PR program
by depressive symptomatology. Note. Analyses controlled for
gender specific predictors of completion indicated in Table 1.completion of PR among women, but not among men. We
also identified exercise capacity (6-min walk test distance)
as an independent predictor of PR completion in women.
Finally, in a post-hoc analysis we found that depressed
mood was significantly more correlated with fatigue in men
than in women.
Results clearly indicate that depressed mood is an
important predictor of completion of community based PR
among women. Given these and previous findings, depres-
sion should be assessed at intake and considered a risk
factor for non-completion among women. It is tempting to
conclude from these results that depression is not partic-
ularly important for community based PR completion
among men with COPD, but this interpretation is compli-
cated by the fact that fatigue (which was controlled for in
multivariate analyses among men) is a symptom of both
COPD and major depressive disorder. In fact, two items on
the CES-D directly assess fatigue: “I felt that everything I
did was an effort” and “I could not get going”. Thus, fatigue
measured on the CRQ may be a symptom of depression,
COPD, or both conditions. Although the relationship be-
tween fatigue and depression in COPD patients has not
been extensively studied, there are data suggesting that
men are more likely to express somatic complaints (such as
fatigue) [32] rather than emotional concerns. Further,
there is evidence that relationships between fatigue and
emotions differ by gender in heart failure patients [33]. Our
post-hoc analysis showing a higher correlation between
depressed mood and fatigue in men than in women suggests
that similar differences may exist among COPD patients.
Further, there is some evidence that depression is partic-
ularly linked to early mortality in men with COPD. In a large
sample (n > 35,000) of primary care patients with COPD in
the UK, Schneider et al. [13] found that depression was
strongly predictive of 1 year mortality in men, but not in
women. Thus, the current findings should not be used to
dismiss the importance of depression symptoms among men
with COPD.
It is notable that patients in the current sample had
access to on-site assessment and brief psychotherapy from
a clinical psychologist. Thus, more intensive depression
treatment or more targeted functional support for atten-
dance might be needed to address depressive symptoms
and prevent PR non-completion. There is limited prior work
on treatment of depression in patients with COPD, but
there is some evidence to support the effectiveness
cognitive-behavioral psychotherapies for improving
depression in this population [34]. Depression treatments
that require patients to attend additional appointments at
separate locations are likely unfeasible for patients already
struggling with regular PR attendance. Further, many bar-
riers to PR attendance and completion are logistical (e.g.,
routine disruption, transportation, lack of support [11]),
thus any psychotherapy intervention targeting PR atten-
dance should target mood and include active, practical
problem-solving of logistical barriers. Behavioral Activation
and Problem-solving Therapy are two cognitive-behavioral
treatment packages that 1) focus on practical problem-
solving, 2) have been effective for treating depression in
other chronically ill populations, and 3) have been suc-
cessfully integrated into medical treatment settings
[35,36]. These treatments may be particularly fitting to
1012 A.M. Busch et al.simultaneously target PR completion and improved mood,
and there is also evidence that these treatments can be
provided remotely (e.g. [37]), minimizing the need for pa-
tients travel to extra sessions.
Results also suggest that higher exercise capacity may be
a gender specific predictor of PR completion. It may be the
case that the exercise components or PR are more physi-
cally aversive or more anxiety producing for women when
their exercise capacity is low. Why low exercise capacity is
predictive of non-completion in women but not men in this
sample is unknown. It is possible that women who came of
age before Title IX was passed in 1972 are less comfortable
exercising in a public setting than men of the same gener-
ation. One previous study suggests exercise capacity
measured by walk distance is predictive of PR completion
[8], while two other studies found that it was not [38,39],
but none of these studies reported gender specific results.
Several variables found to predict PR completion in
previous studies, including living alone, body composition,
travel distance, dyspnea, and oxygen use [8,38,40], were
not predictive of completion in the current study. In addi-
tion, current smoking, which has been linked to PR non-
completion in several samples, was not relevant to the
current sample because it only included former and never
smokers. Current smokers rarely attended this PR program
because Medicare guidelines in this area at the time of data
collection required that a patient have quit smoking at
least 3 months prior to enrollment.
To our knowledge, this is the first study of predictors of
PR completion 1) using a sample drawn from a community-
based PR program in the US and 2) examining gender spe-
cific predictors of PR completion. Limitations of this study
include 1) a smaller, mostly Caucasian sample, 2) a care-
fully defined and ecologically valid but nonetheless
dichotomized outcome variable, 3) lack of a clinical inter-
view to determine psychiatric diagnostic status, and 4) lack
of information on patient utilization of psychiatric in-
terventions as part of the PR program and concurrent psy-
chiatric treatments outside of the PR program.
Conclusions
Depressive symptoms and Major Depressive Disorder are
common among patients with COPD and predict future
morbidity and mortality. Depressed mood predicts non-
completion of PR, especially among women. These results
and others [11] suggest that non-adherence to pulmonary
rehabilitation may be one pathway through which
depressed mood impacts COPD morbidity and mortality.
Screening and brief treatment of depression should be
considered in practice, and continued research on the
interaction between gender, depression, and adherence
with PR among those with COPD is warranted.
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